Case Study: HealthTech ($15M Total Raise)
Why We Told a HealthTech Founder Not to Raise $15M.
A HealthTech company approached MoonshotNX seeking to raise $15M in growth capital through a single fundraising round. Following assessment, valuation review and Investment Committee analysis, we advised management to restructure the raise into two phases. The company first secured a $5M strategic Series A investor within four months, creating additional market validation and investor confidence. Nine months later, the second raise closed, bringing total capital raised to $15M and establishing a stronger long-term capital structure than originally planned.
Advisory.
The company partnered with MoonshotNX seeking to raise $15M in growth capital. Management initially planned to pursue the entire raise through a single fundraising process. Our assessment suggested a different approach.
Following Investor Room onboarding, Lions Den review, valuation analysis, market assessment and Investment Committee evaluation, MoonshotNX recommended restructuring the raise into two separate rounds. The objective was to secure strategic validation first and growth capital second.
We worked closely with management to refine valuation positioning, strengthen investor messaging, improve supporting materials and identify investors whose mandates aligned with both the business and the sector. The first phase focused on attracting a strategic lead investor capable of contributing more than capital alone.
The result was a $5M strategic Series A completed within four months. With a lead investor in place and investor confidence significantly stronger, the company returned to market and successfully closed a further $10M growth round nine months later, bringing total capital raised to $15M.
The investor response before MoonshotNX.
Every investor below either reviewed the opportunity, requested additional materials, participated in diligence discussions or provided feedback during the fundraising process.
Prior to MoonshotNX, investors consistently questioned the size and structure of the proposed $15M raise. While there was strong interest in the business, many investors felt management was attempting to raise too much capital before securing sufficient institutional validation. Following valuation analysis, Investment Committee review and a revised two-stage funding strategy, investor conversations shifted dramatically.
Healthcare Growth Fund
“The revised structure makes considerably more sense. We'd like to review the first-round investor participation and updated funding plan.”
Institutional Investor
“The strategic lead investor significantly reduces execution risk. Please send the updated materials.”
Healthcare Venture Fund
“This is a stronger proposition than the original raise structure. Happy to continue diligence.”
Life Sciences Investor
“The phased approach creates a much clearer path to value creation and milestone achievement.”
Growth Equity Fund
“The first close provides meaningful institutional validation. We'd like to discuss participation in the second round.”
Strategic Investor
“The revised capital plan is significantly easier to support than a single $15M raise.”
The findings.
The MoonshotNX assessment combines Investor Room analysis, Lions Den review, more than 15,000 datapoints and human analyst review. The objective is not to tell founders what they want to hear. The objective is to identify what investors are actually seeing.
The assessment revealed that the company was not facing a demand problem. Investors understood the market opportunity, believed in the management team and recognised the commercial potential of the business. The challenge was that the company was attempting to raise too much capital before establishing the level of institutional validation investors expected to see.
The Outcome.
The findings changed the structure of the raise. Rather than pursuing a single $15M round, the company followed the MoonshotNX recommendation to secure strategic capital first and growth capital second.
Investor targeting was narrowed, valuation positioning was strengthened and the fundraising narrative was rebuilt around the milestones investors needed to see before committing larger amounts of capital.
The first phase resulted in a $5M strategic Series A investment completed within four months.
That transaction fundamentally changed how the market viewed the opportunity. With strategic validation in place, investor confidence increased, diligence cycles accelerated and larger growth investors became significantly more receptive to the opportunity.
Nine months later, the company successfully completed a further $10M raise.
Total capital raised reached $15M.
The outcome was not simply a successful raise. The company emerged with stronger investors, a stronger capital structure and a stronger platform for future growth.
Raising your next round?
Every successful raise starts with investor confidence. Before capital comes clarity, positioning, valuation, readiness and the ability to answer the questions investors are actually asking. If you're preparing for a raise, MoonshotNX can help you build a stronger investment case and a clearer path to capital.
Book a discovery call →